Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Rbms3 | Rat | 1,2-dichloroethane | increases expression | ISO | Rbms3 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of RBMS3 mRNA | CTD | PMID:28960355 | Rbms3 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Rbms3 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of RBMS3 mRNA | CTD | PMID:22206623 | Rbms3 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Rbms3 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of RBMS3 mRNA | CTD | PMID:17555576 | Rbms3 | Rat | 17beta-estradiol | affects expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Estradiol affects the expression of RBMS3 mRNA | CTD | PMID:22574217 | Rbms3 | Rat | 17beta-estradiol | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of RBMS3 mRNA | CTD | PMID:20660070 | Rbms3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RBMS3 mRNA | CTD | PMID:32109520 | Rbms3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RBMS3 mRNA | CTD | PMID:33387578 | Rbms3 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RBMS3 mRNA | CTD | PMID:32109520 | Rbms3 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Rbms3 (Mus musculus) | 6480464 | 2,2',4,4',5-brominated diphenyl ether affects the expression of RBMS3 mRNA | CTD | PMID:38648751 | Rbms3 | Rat | 2-butoxyethanol | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | n-butoxyethanol results in decreased expression of RBMS3 mRNA | CTD | PMID:19812364 | Rbms3 | Rat | 2-methylcholine | affects expression | ISO | RBMS3 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of RBMS3 mRNA | CTD | PMID:21179406 | Rbms3 | Rat | 3',5'-cyclic UMP | affects binding | ISO | RBMS3 (Homo sapiens) | 6480464 | RBMS3 protein binds to cyclic 3',5'-uridine monophosphate | CTD | PMID:30528433 | Rbms3 | Rat | 3-methylcholanthrene | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | Methylcholanthrene results in decreased expression of RBMS3 mRNA | CTD | PMID:20713471 | Rbms3 | Rat | 4,4'-sulfonyldiphenol | decreases methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of RBMS3 gene | CTD | PMID:31601247 | Rbms3 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of RBMS3 mRNA | CTD | PMID:28973697 | Rbms3 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of RBMS3 mRNA | CTD | PMID:24780913 | Rbms3 | Rat | 8-Br-cAMP | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RBMS3 mRNA | CTD | PMID:22079614 | Rbms3 | Rat | aflatoxin B1 | increases methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of RBMS3 intron | CTD | PMID:30157460 | Rbms3 | Rat | Aflatoxin B2 alpha | increases methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of RBMS3 intron | CTD | PMID:30157460 | Rbms3 | Rat | all-trans-retinoic acid | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of RBMS3 mRNA | CTD | PMID:21934132|PMID:23724009 | Rbms3 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of RBMS3 mRNA | CTD | PMID:35163327 | Rbms3 | Rat | antirheumatic drug | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of RBMS3 mRNA | CTD | PMID:24449571 | Rbms3 | Rat | aristolochic acid A | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of RBMS3 mRNA | CTD | PMID:33212167 | Rbms3 | Rat | arsane | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RBMS3 more ... | CTD | PMID:39836092 | Rbms3 | Rat | arsenic atom | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RBMS3 more ... | CTD | PMID:39836092 | Rbms3 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of RBMS3 gene | CTD | PMID:28931070|PMID:35440735 | Rbms3 | Rat | auranofin | affects response to substance | ISO | RBMS3 (Homo sapiens) | 6480464 | RBMS3 protein affects the susceptibility to Auranofin | CTD | PMID:36414028 | Rbms3 | Rat | benzo[a]pyrene | increases mutagenesis | ISO | RBMS3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of RBMS3 gene | CTD | PMID:25435355 | Rbms3 | Rat | benzo[a]pyrene | affects methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of RBMS3 intron | CTD | PMID:30157460 | Rbms3 | Rat | benzo[a]pyrene | affects methylation | ISO | Rbms3 (Mus musculus) | 6480464 | Benzo(a)pyrene affects the methylation of RBMS3 intron | CTD | PMID:27901495 | Rbms3 | Rat | benzo[a]pyrene | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of RBMS3 mRNA | CTD | PMID:20713471 | Rbms3 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RBMS3 mRNA | CTD | PMID:19150397 | Rbms3 | Rat | bisphenol A | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of RBMS3 mRNA | CTD | PMID:22576693 | Rbms3 | Rat | bisphenol A | decreases methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of RBMS3 gene | CTD | PMID:31601247 | Rbms3 | Rat | bisphenol A | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RBMS3 gene | CTD | PMID:31601247 | Rbms3 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RBMS3 mRNA | CTD | PMID:25181051 | Rbms3 | Rat | bisphenol A | increases methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of RBMS3 gene | CTD | PMID:22576693 | Rbms3 | Rat | butanal | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of RBMS3 mRNA | CTD | PMID:26079696 | Rbms3 | Rat | Butylbenzyl phthalate | affects methylation | ISO | Rbms3 (Mus musculus) | 6480464 | butylbenzyl phthalate affects the methylation of RBMS3 intron | CTD | PMID:28392331 | Rbms3 | Rat | carbon nanotube | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of RBMS3 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681|PMID:25620056 | Rbms3 | Rat | CGP 52608 | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RBMS3 gene] | CTD | PMID:28238834 | Rbms3 | Rat | choline | multiple interactions | ISO | Rbms3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Rbms3 | Rat | chromium(6+) | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression more ... | CTD | PMID:38479592 | Rbms3 | Rat | cisplatin | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of RBMS3 mRNA | CTD | PMID:27392435 | Rbms3 | Rat | cisplatin | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of RBMS3 mRNA | CTD | PMID:27392435 | Rbms3 | Rat | crocidolite asbestos | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | Asbestos, Crocidolite results in decreased expression of RBMS3 mRNA | CTD | PMID:29279043 | Rbms3 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of RBMS3 mRNA | CTD | PMID:26577399 | Rbms3 | Rat | cyclosporin A | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of RBMS3 mRNA | CTD | PMID:20106945 | Rbms3 | Rat | dexamethasone | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | Dexamethasone results in decreased expression of RBMS3 mRNA | CTD | PMID:22733784 | Rbms3 | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of RBMS3 mRNA | CTD | PMID:21551480 | Rbms3 | Rat | dorsomorphin | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Rbms3 | Rat | doxorubicin | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of RBMS3 mRNA | CTD | PMID:29803840 | Rbms3 | Rat | folic acid | multiple interactions | ISO | Rbms3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Rbms3 | Rat | folic acid | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of RBMS3 mRNA | CTD | PMID:25629700 | Rbms3 | Rat | fulvestrant | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RBMS3 gene | CTD | PMID:31601247 | Rbms3 | Rat | geldanamycin | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of RBMS3 mRNA | CTD | PMID:26705709 | Rbms3 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of RBMS3 mRNA | CTD | PMID:33387578 | Rbms3 | Rat | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of RBMS3 gene | CTD | PMID:35440735 | Rbms3 | Rat | L-methionine | multiple interactions | ISO | Rbms3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Rbms3 | Rat | mercury dibromide | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of RBMS3 mRNA | CTD | PMID:26272509 | Rbms3 | Rat | mercury dibromide | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Rbms3 | Rat | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of RBMS3 gene; [Permethrin co-treated with DEET] more ... | CTD | PMID:33148267 | Rbms3 | Rat | nickel atom | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Nickel results in decreased expression of RBMS3 mRNA | CTD | PMID:25583101 | Rbms3 | Rat | nickel sulfate | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of RBMS3 mRNA | CTD | PMID:22714537 | Rbms3 | Rat | okadaic acid | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of RBMS3 mRNA | CTD | PMID:38832940 | Rbms3 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of RBMS3 mRNA | CTD | PMID:25729387 | Rbms3 | Rat | ozone | multiple interactions | ISO | Rbms3 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RBMS3 more ... | CTD | PMID:34911549 | Rbms3 | Rat | panobinostat | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Rbms3 | Rat | paracetamol | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of RBMS3 mRNA | CTD | PMID:29067470 | Rbms3 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RBMS3 mRNA | CTD | PMID:33387578 | Rbms3 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Rbms3 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of RBMS3 mRNA | CTD | PMID:37995155 | Rbms3 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of RBMS3 mRNA | CTD | PMID:35163327 | Rbms3 | Rat | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of RBMS3 gene; [Permethrin co-treated with DEET] more ... | CTD | PMID:33148267 | Rbms3 | Rat | phenylmercury acetate | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of RBMS3 mRNA | CTD | PMID:26272509 | Rbms3 | Rat | phenylmercury acetate | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Rbms3 | Rat | potassium chromate | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of RBMS3 mRNA | CTD | PMID:22714537 | Rbms3 | Rat | potassium dichromate | increases expression | ISO | Rbms3 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of RBMS3 mRNA | CTD | PMID:23608068 | Rbms3 | Rat | progesterone | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of RBMS3 mRNA | CTD | PMID:20660070 | Rbms3 | Rat | propiconazole | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | propiconazole results in decreased expression of RBMS3 mRNA | CTD | PMID:21278054 | Rbms3 | Rat | SB 431542 | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Rbms3 | Rat | silver atom | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | Silver results in decreased expression of RBMS3 mRNA | CTD | PMID:27131904 | Rbms3 | Rat | silver(0) | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | Silver results in decreased expression of RBMS3 mRNA | CTD | PMID:27131904 | Rbms3 | Rat | sodium arsenite | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of RBMS3 mRNA | CTD | PMID:22714537|PMID:34032870|PMID:38568856 | Rbms3 | Rat | sodium arsenite | affects methylation | ISO | Rbms3 (Mus musculus) | 6480464 | sodium arsenite affects the methylation of RBMS3 gene | CTD | PMID:39894169 | Rbms3 | Rat | sodium arsenite | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RBMS3 more ... | CTD | PMID:39836092 | Rbms3 | Rat | sulforaphane | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of RBMS3 mRNA | CTD | PMID:31838189 | Rbms3 | Rat | sunitinib | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of RBMS3 mRNA | CTD | PMID:31533062 | Rbms3 | Rat | tamoxifen | affects expression | ISO | Rbms3 (Mus musculus) | 6480464 | Tamoxifen affects the expression of RBMS3 mRNA | CTD | PMID:17555576 | Rbms3 | Rat | tetrachloromethane | affects expression | ISO | Rbms3 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of RBMS3 mRNA | CTD | PMID:17484886 | Rbms3 | Rat | thiram | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Thiram results in decreased expression of RBMS3 mRNA | CTD | PMID:38568856 | Rbms3 | Rat | titanium dioxide | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of RBMS3 mRNA | CTD | PMID:29264374 | Rbms3 | Rat | titanium dioxide | increases expression | ISO | Rbms3 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of RBMS3 mRNA | CTD | PMID:35295148 | Rbms3 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of RBMS3 mRNA | CTD | PMID:25729387 | Rbms3 | Rat | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of RBMS3 mRNA | CTD | PMID:25729387 | Rbms3 | Rat | trichostatin A | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Rbms3 | Rat | trichostatin A | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of RBMS3 mRNA | CTD | PMID:24935251|PMID:26272509|PMID:27188386 | Rbms3 | Rat | triclosan | decreases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of RBMS3 mRNA | CTD | PMID:30510588 | Rbms3 | Rat | trimellitic anhydride | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of RBMS3 mRNA | CTD | PMID:19042947 | Rbms3 | Rat | troglitazone | decreases expression | ISO | Rbms3 (Mus musculus) | 6480464 | troglitazone results in decreased expression of RBMS3 mRNA | CTD | PMID:28973697 | Rbms3 | Rat | valproic acid | decreases methylation | ISO | RBMS3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of RBMS3 gene | CTD | PMID:29154799 | Rbms3 | Rat | valproic acid | affects expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of RBMS3 mRNA | CTD | PMID:25979313 | Rbms3 | Rat | valproic acid | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Rbms3 | Rat | valproic acid | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of RBMS3 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369 | Rbms3 | Rat | vinclozolin | decreases methylation | EXP | | 6480464 | vinclozolin results in decreased methylation of RBMS3 gene | CTD | PMID:31079544 | Rbms3 | Rat | vorinostat | multiple interactions | ISO | RBMS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Rbms3 | Rat | vorinostat | increases expression | ISO | RBMS3 (Homo sapiens) | 6480464 | vorinostat results in increased expression of RBMS3 mRNA | CTD | PMID:26272509|PMID:27188386 | |





















